2/26/2013

Researchers looked at the records of nearly 300,000 adult patients with attention-deficit/hyperactivity disorder and found that those who took amphetamines or atomoxetine were not more likely to develop stroke, heart attack or other serious heart problems during the first few months of treatment than those who didn't take the drugs. The study appeared in the journal PLoS One.

Full Story:
DailyRx.com

Related Summaries